Success Metrics

Clinical Success Rate
92.9%

Based on 13 completed trials

Completion Rate
93%(13/14)
Active Trials
4(19%)
Results Posted
23%(3 trials)
Terminated
1(5%)

Phase Distribution

Ph early_phase_1
2
10%
Ph not_applicable
5
24%
Ph phase_3
4
19%
Ph phase_2
10
48%

Phase Distribution

2

Early Stage

10

Mid Stage

4

Late Stage

Phase Distribution21 total trials
Early Phase 1First-in-human
2(9.5%)
Phase 2Efficacy & side effects
10(47.6%)
Phase 3Large-scale testing
4(19.0%)
N/ANon-phased studies
5(23.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

92.9%

13 of 14 finished

Non-Completion Rate

7.1%

1 ended early

Currently Active

4

trials recruiting

Total Trials

21

all time

Status Distribution
Active(4)
Completed(13)
Terminated(1)
Other(3)

Detailed Status

Completed13
Recruiting4
unknown3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
4
Success Rate
92.9%
Most Advanced
Phase 3

Trials by Phase

Early Phase 12 (9.5%)
Phase 210 (47.6%)
Phase 34 (19.0%)
N/A5 (23.8%)

Trials by Status

recruiting419%
completed1362%
terminated15%
unknown314%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT05602194Phase 3

Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

Recruiting
NCT07201714Early Phase 1

Oral Carnitine in Heart Failure Patients

Recruiting
NCT07266259Not Applicable

Effect of Levocarnitine Plus Myoinositol Versus Myoinositol Alone on Hormonal and Insulin Resistance in PCOS Women

Recruiting
NCT03953703Phase 2

Levocarnitine for Dry Eye in Sjogren's Syndrome

Completed
NCT03564678Phase 2

Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia

Terminated
NCT05501899Early Phase 1

Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia

Recruiting
NCT00091169Phase 3

Levocarnitine in Treating Fatigue in Cancer Patients

Completed
NCT00000892Not Applicable

A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Completed
NCT00001087Phase 2

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Completed
NCT00000912Phase 2

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

Completed
NCT00000885Phase 2

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Completed
NCT04145245Phase 2

A Randomized Controlled Trial to Assess the Effect of L-carnitine in Patients With Diabetic Peripheral Neuropathy to Relief Pain and Symptom Improvement

Unknown
NCT01665092Phase 2

Rapid Administration of Carnitine in sEpsis

Completed
NCT03372772Not Applicable

Effect of Levocarnitine Supplementation for the Management of Fatigue in Levothyroxine-Treated Hypothyroid Patients

Unknown
NCT01893892Not Applicable

Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms

Completed
NCT00001082Phase 3

The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients

Completed
NCT00002379Phase 2

The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Completed
NCT00002398Not Applicable

Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations

Completed
NCT00002220Phase 3

Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir

Completed
NCT00002219Phase 2

Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children

Unknown

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
21